[Prolyl endopeptidase inhibitors].
Aoyagi
T
T
Showa College of Pharmaceutical Sciences, Tokyo, Japan.
Muraoka
Y
Y
D000544:Alzheimer Disease / Q000201:enzymology; D000818:Animals; D003864:Depression, Chemical; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000201:enzymology; D015394:Molecular Structure; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology*; D000085822:Prolyl Oligopeptidases; D012697:Serine Endopeptidases / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D009842:Oligopeptides; D015842:Serine Proteinase Inhibitors; C071400:poststatin; D012697:Serine Endopeptidases; C000705287:PREPL protein, human; D000085822:Prolyl Oligopeptidases